Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.
about
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Anti-steatotic and anti-fibrot ...... n non-alcoholic liver disease.
@en
type
label
Anti-steatotic and anti-fibrot ...... n non-alcoholic liver disease.
@en
prefLabel
Anti-steatotic and anti-fibrot ...... n non-alcoholic liver disease.
@en
P2093
P2860
P356
P1476
Anti-steatotic and anti-fibrot ...... n non-alcoholic liver disease.
@en
P2093
David E Smith
Dawoon Jung
Itzhak D Goldberg
Jing-Song Li
Latha Paka
Michael Yamin
P2860
P304
P356
10.3748/WJG.V23.I23.4181
P407
P577
2017-06-01T00:00:00Z